Table 1.
Baseline Characteristics of Patients According to ICAM-1 Expression
| Characteristics | ICAM-1 Negative (n = 86, 64%) | ICAM-1 Positive (n = 48, 36%) | p Value | ||
|---|---|---|---|---|---|
| Age | 0.371 | ||||
| median | 52 | 51 | |||
| range | 20–73 | 40–76 | |||
| Sex | 0.149 | ||||
| male | 56 (60.2) | 37 (39.8) | |||
| female | 30 (73.2) | 11 (26.8) | |||
| Lauren’s classification | 0.157 | ||||
| intestinal | 32 (69.6) | 14 (30.4) | |||
| diffuse | 43 (57.3) | 32 (42.7) | |||
| mixed and unclassifiable | 11 (84.6) | 2 (15.4) | |||
| HER2 status | 0.331 | ||||
| negative | 78 (62.9) | 46 (37.1) | |||
| positive | 8 (80) | 2 (20) | |||
| Surgery types | 0.262 | ||||
| subtotal gastrectomy | 58 (68.2) | 27 (31.8) | |||
| total gastrectomy | 28 (57.1) | 21 (42.9) | |||
| Stage | 0.002 | ||||
| II | 43 (79.6) | 11 (20.4) | |||
| III | 43 (53.8) | 37 (46.3) | |||
| T stage | 0.102 | ||||
| 1 | 2 (66.7) | 1 (33.3) | |||
| 2 | 36 (75) | 12 (25) | |||
| 3 | 47 (57.3) | 35 (42.7) | |||
| 4 | 1 (100) | 0 | |||
| N stage | 0.012 | ||||
| 0 | 11 (73.3) | 4 (26.7) | |||
| 1 | 57 (72.2) | 22 (27.8) | |||
| 2 | 18 (45) | 22 (55) | |||
| Adjuvant chemotherapy | 0.979 | ||||
| no | 45 (64.3) | 25 (35.7) | |||
| yes | 41 (64.1) | 23 (35.9) | |||